Serotonergic modulation of taste

味觉的血清素调节

基本信息

  • 批准号:
    7925655
  • 负责人:
  • 金额:
    $ 5.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-27 至 2012-08-26
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The goal ofthis application is to provide specialized training in animal taste psychophysics, a field which is indispensablle in linking neurobiological mechanisms of the gustatory system to behaviorally assessed taste function. To achieve this goal, experiments will be conducted using psychophysical procedures to assess the effects of pharmacological modulation of serotonin on taste-guided behavior in rats. Drugs that affect ingestive behavior are often assumed to do so by modulating the rewarding characteristics of the taste of foods and fluids. Understanding the mechanisms of action of these drugs is crucial to defining the role of the hedonic aspect of taste in eating behavior, which indisputably is contributing to this nation's growing problem with obesity. However, it is premature to conclude that a drug only affects hedonic components of taste without first assessing its effects on sensory-discriminative function. Serotonin is a ubiquitous neurotrasmitter that has actions in areas of the brain and periphery involved in taste and reward. Drugs that impinge on serotonergic transmission affect ingestion of food and fluid and impact taste perceptions in depressed and healthy humans. The extent to which this results from hedonic or discriminative aspects of taste has yet to be determined. The experiments in this proposal are designed to explicitly test the dose-related effect of an inhibitor and a facilitator of serotonin reuptake (and thus a functional agonist and antagonist, respectively) on performance in psychophysical tasks. These tasks assess concentration-dependent changes in the detection of, identification of, and hedonic responsiveness to taste stimuli. In a field advancing rapidly toward understanding the physiologic hardware of taste perception, scientists fluent in behavioral techniques are needed to link the growing body of information concerning the neurobiological, cellular, and molecular mechanisms of taste processing to its final common output - behavior. PUBLIC HEALTH RELEVANCE: The experiments in this proposal are designed to assess how drugs not only affect how "good" or "bad" something tastes, but also how strong it is and what it tastes like, independent of its rewarding or aversive characterisfics. These studies will help define how chemical signaling in the body affects taste-guided behavior (i.e., eating and drinking). This informafion may help clinicians understand and more effectively treat patients with eating disorders affected by the rewarding characteristics of taste (e.g., obesity) and psychiatric disorders in which taste percepfions are distorted (e.g., depression).
描述(由申请人提供):本申请的目的是提供动物味觉心理物理学的专门培训,这是一个将味觉系统的神经生物学机制与行为评估味觉功能联系起来的不可或缺的领域。为了实现这一目标,将使用心理物理程序进行实验,以评估5-羟色胺的药理学调节对大鼠味觉引导行为的影响。影响摄食行为的药物通常被认为是通过调节食物和液体味道的奖励特性来实现的。了解这些药物的作用机制对于确定味觉的享乐方面在饮食行为中的作用至关重要,这无可争议地导致了这个国家日益严重的肥胖问题。然而,在没有首先评估其对感觉辨别功能的影响的情况下,得出药物只影响味觉的享乐成分的结论还为时过早。5-羟色胺是一种普遍存在的神经递质,在大脑和与味觉和奖赏有关的外围区域起作用。影响多巴胺能传递的药物影响食物和液体的摄入,并影响抑郁和健康人群的味觉。这在多大程度上是由品味的享乐或歧视方面造成的,还有待确定。本提案中的实验旨在明确测试5-羟色胺再摄取抑制剂和促进剂(因此分别为功能性激动剂和拮抗剂)对心理物理任务性能的剂量相关影响。这些任务评估浓度依赖性的变化,检测,识别和享乐的味觉刺激的反应。在一个朝着理解味觉的生理硬件快速发展的领域,需要精通行为技术的科学家将越来越多的关于味觉加工的神经生物学、细胞和分子机制的信息与其最终的共同输出--行为联系起来。 公共卫生相关性:该提案中的实验旨在评估药物如何不仅影响某种东西的“好”或“坏”味道,而且影响它的强度和味道,而不受其奖励或厌恶特征的影响。这些研究将有助于确定体内的化学信号如何影响味觉引导行为(即,吃和喝)。这些信息可以帮助临床医生理解并更有效地治疗受味觉奖励特征影响的进食障碍患者(例如,肥胖)和味觉感知被扭曲的精神疾病(例如,抑郁症)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLARE M MATHES其他文献

CLARE M MATHES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLARE M MATHES', 18)}}的其他基金

Central Dopaminergic Modulation of Sensory and Reward Taste Function in Rats.
大鼠感觉和奖赏味觉功能的中枢多巴胺能调节。
  • 批准号:
    9021624
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
Central Dopaminergic Modulation of Sensory and Reward Taste Function in Rats.
大鼠感觉和奖赏味觉功能的中枢多巴胺能调节。
  • 批准号:
    8911965
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
Central Dopaminergic Modulation of Sensory and Reward Taste Function in Rats.
大鼠感觉和奖赏味觉功能的中枢多巴胺能调节。
  • 批准号:
    8688653
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
Central Dopaminergic Modulation of Sensory and Reward Taste Function in Rats.
大鼠感觉和奖赏味觉功能的中枢多巴胺能调节。
  • 批准号:
    8804941
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
Serotonergic modulation of taste
味觉的血清素调节
  • 批准号:
    7806827
  • 财政年份:
    2009
  • 资助金额:
    $ 5.05万
  • 项目类别:
Serotonergic modulation of taste
味觉的血清素调节
  • 批准号:
    8135309
  • 财政年份:
    2009
  • 资助金额:
    $ 5.05万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了